Bausch Health Companies Inc. (BHC) Stock Overview
Explore Bausch Health Companies Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bausch Health Companies Inc. (BHC)
Key Financials
Key Financials
Market Cap
2.2B
P/E Ratio
-1.97
EPS (TTM)
$3.92
ROE
0.89%
BHC Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Bausch Health Companies Inc. (NYSE: BHC) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Bausch Health Companies Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BHC on the NYSE shows an RSI of 44.73, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.64 for the NYSE listing.
Key metrics behind Bausch Health Companies Inc.'s NYSE-traded stock include a P/E ratio of -1.97 and a market capitalization of 2.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BHC on the NYSE.